Pathstone Holdings’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
Other funds holding IDXX
Pathstone Holdings's IDXX Position: Q3 2026 in Review
Pathstone Holdings reduced its Idexx Laboratories (IDXX) stake by 2.9% in Q3 2026, selling an estimated $332K and leaving 20,018 shares worth $10.4M. The position accounts for 0.03% of the portfolio, ranked #414.
Pathstone Holdings first reported a position in IDXX in Q4 2023 and has held it in 12 quarters since. The position peaked at $13.5M in Q1 2024. 1,276 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.
- Pathstone Holdings held 20,018 shares of Idexx Laboratories worth $10.4M as of Q3 2026.
- Pathstone Holdings sold 605 Idexx Laboratories shares in Q3 2026, an estimated $332K.
- Idexx Laboratories made up 0.03% of Pathstone Holdings's portfolio in Q3 2026, its #414 holding.
- Pathstone Holdings first reported a position in Idexx Laboratories in Q4 2023 and has held it in 12 quarters since.
- Pathstone Holdings's Idexx Laboratories position peaked at $13.5M in Q1 2024.
- 1,276 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.
Based on Pathstone Holdings's 13F filing for Q3 2026, filed 13 Nov 2026.